Cutera has signed a binding agreement of $5.1m to purchase certain assets of Iridex's aesthetic business.
Cutera Kevin president and CEO Connors said with Cutera’s premium Excel V laser to Iridex’s portable VariLite dual wavelength system, they will enable physicians to effectively treat a wider range of vascular aesthetic indications at multiple price points.
Iridex president and CEO Dominik Beck said the acquisition of their aesthetic laser assets by Cutera allows them to refocus all of their resources on the substantial and growing ophthalmology opportunity.
"We will continue to strengthen our domestic and international ophthalmology presence by leveraging the brand equity and relationships established in that business over three decades and by driving a new paradigm in the treatment of retinal diseases," Beck said.